In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need
Molecular characterization of corn glutathione S-transferase isozymes involved in herbicide detoxication
Key Takeaways GLP-1 medications are associated with a higher risk of gallstones and gallbladder disease, and FDA labeling for Zepbound and Wegovy lists gallstones and acute cholecystitis as possible risks
In many cases, the issue is not that the drug cannot work, but that the onboarding plan was not sustainable
Wegovy allows 28 days at room temperature
Scan the menu for grilled chicken, fish, or shrimp dishes